Abeona Therapeutics (ABEO) Competitors $5.81 0.00 (0.00%) As of 10:32 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock ABEO vs. DVAX, LQDA, CALT, GPCR, MNKD, HROW, ELVN, PCRX, AUPH, and WVEShould you be buying Abeona Therapeutics stock or one of its competitors? The main competitors of Abeona Therapeutics include Dynavax Technologies (DVAX), Liquidia (LQDA), Calliditas Therapeutics AB (publ) (CALT), Structure Therapeutics (GPCR), MannKind (MNKD), Harrow (HROW), Enliven Therapeutics (ELVN), Pacira BioSciences (PCRX), Aurinia Pharmaceuticals (AUPH), and Wave Life Sciences (WVE). These companies are all part of the "medical" sector. Abeona Therapeutics vs. Its Competitors Dynavax Technologies Liquidia Calliditas Therapeutics AB (publ) Structure Therapeutics MannKind Harrow Enliven Therapeutics Pacira BioSciences Aurinia Pharmaceuticals Wave Life Sciences Dynavax Technologies (NASDAQ:DVAX) and Abeona Therapeutics (NASDAQ:ABEO) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their media sentiment, valuation, risk, analyst recommendations, profitability, community ranking, institutional ownership, dividends and earnings. Is DVAX or ABEO more profitable? Abeona Therapeutics has a net margin of 0.00% compared to Dynavax Technologies' net margin of -20.39%. Dynavax Technologies' return on equity of 3.59% beat Abeona Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets Dynavax Technologies-20.39% 3.59% 2.20% Abeona Therapeutics N/A -118.82%-52.48% Do insiders and institutionals hold more shares of DVAX or ABEO? 97.0% of Dynavax Technologies shares are owned by institutional investors. Comparatively, 80.6% of Abeona Therapeutics shares are owned by institutional investors. 3.0% of Dynavax Technologies shares are owned by insiders. Comparatively, 5.4% of Abeona Therapeutics shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term. Which has more volatility and risk, DVAX or ABEO? Dynavax Technologies has a beta of 1.07, indicating that its stock price is 7% more volatile than the S&P 500. Comparatively, Abeona Therapeutics has a beta of 1.55, indicating that its stock price is 55% more volatile than the S&P 500. Which has higher earnings & valuation, DVAX or ABEO? Dynavax Technologies has higher revenue and earnings than Abeona Therapeutics. Dynavax Technologies is trading at a lower price-to-earnings ratio than Abeona Therapeutics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioDynavax Technologies$277.25M4.28$27.31M-$0.52-18.99Abeona Therapeutics$3.50M84.93-$63.73M-$1.27-4.57 Does the media favor DVAX or ABEO? In the previous week, Abeona Therapeutics had 1 more articles in the media than Dynavax Technologies. MarketBeat recorded 4 mentions for Abeona Therapeutics and 3 mentions for Dynavax Technologies. Dynavax Technologies' average media sentiment score of 1.53 beat Abeona Therapeutics' score of 0.19 indicating that Dynavax Technologies is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Dynavax Technologies 3 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Abeona Therapeutics 0 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Does the MarketBeat Community prefer DVAX or ABEO? Abeona Therapeutics received 52 more outperform votes than Dynavax Technologies when rated by MarketBeat users. Likewise, 69.42% of users gave Abeona Therapeutics an outperform vote while only 65.79% of users gave Dynavax Technologies an outperform vote. CompanyUnderperformOutperformDynavax TechnologiesOutperform Votes47765.79% Underperform Votes24834.21% Abeona TherapeuticsOutperform Votes52969.42% Underperform Votes23330.58% Do analysts prefer DVAX or ABEO? Dynavax Technologies presently has a consensus price target of $24.00, indicating a potential upside of 142.99%. Abeona Therapeutics has a consensus price target of $19.25, indicating a potential upside of 231.33%. Given Abeona Therapeutics' stronger consensus rating and higher probable upside, analysts plainly believe Abeona Therapeutics is more favorable than Dynavax Technologies.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Dynavax Technologies 1 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.50Abeona Therapeutics 0 Sell rating(s) 0 Hold rating(s) 5 Buy rating(s) 0 Strong Buy rating(s) 3.00 SummaryAbeona Therapeutics beats Dynavax Technologies on 11 of the 18 factors compared between the two stocks. Get Abeona Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for ABEO and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding ABEO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ABEO vs. The Competition Export to ExcelMetricAbeona TherapeuticsMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$297.09M$2.82B$5.37B$8.68BDividend YieldN/A2.69%5.38%4.23%P/E Ratio-4.5721.4026.1019.38Price / Sales84.93280.81398.82108.60Price / CashN/A40.9225.4426.73Price / Book5.757.407.985.81Net Income-$63.73M-$55.10M$3.15B$248.44M7 Day Performance-3.17%-0.33%1.41%1.40%1 Month Performance-9.50%6.44%6.08%4.85%1 Year Performance33.56%-2.37%42.25%16.01% Abeona Therapeutics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ABEOAbeona Therapeutics3.7977 of 5 stars$5.81flat$19.25+231.3%+26.9%$297.09M$3.50M-4.57N/ADVAXDynavax Technologies4.2384 of 5 stars$10.17-1.0%$24.00+136.0%-14.5%$1.22B$294.62M56.50350Positive NewsLQDALiquidia3.7428 of 5 stars$14.09-0.1%$26.89+90.8%+8.7%$1.20B$14.14M-8.6450CALTCalliditas Therapeutics AB (publ)N/A$40.00flatN/AN/A$1.19B$1.60B-21.62180GPCRStructure Therapeutics1.6875 of 5 stars$20.57-5.1%$76.50+271.9%-51.5%$1.18BN/A-27.80136News CoverageAnalyst ForecastMNKDMannKind2.5679 of 5 stars$3.81+2.7%$10.33+171.2%-25.6%$1.16B$297.60M54.43400HROWHarrow2.2585 of 5 stars$31.54+4.1%$61.40+94.7%+47.6%$1.16B$212.86M-33.55182ELVNEnliven Therapeutics2.6973 of 5 stars$23.09+5.4%$39.60+71.5%-5.4%$1.13BN/A-12.1550High Trading VolumePCRXPacira BioSciences2.2802 of 5 stars$24.34+0.4%$26.44+8.6%-13.6%$1.13B$702.77M-11.99720Positive NewsAUPHAurinia Pharmaceuticals3.1759 of 5 stars$8.14-0.5%$11.50+41.3%+41.6%$1.10B$247.30M-54.26300Positive NewsWVEWave Life Sciences4.2656 of 5 stars$6.85-1.4%$20.50+199.3%+32.6%$1.06B$104.94M-6.17240Analyst Forecast Related Companies and Tools Related Companies Dynavax Technologies Alternatives Liquidia Alternatives Calliditas Therapeutics AB (publ) Alternatives Structure Therapeutics Alternatives MannKind Alternatives Harrow Alternatives Enliven Therapeutics Alternatives Pacira BioSciences Alternatives Aurinia Pharmaceuticals Alternatives Wave Life Sciences Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:ABEO) was last updated on 6/24/2025 by MarketBeat.com Staff From Our PartnersSpecial gold investment soars 2,300% ... 5,090% ... 9,850%In my 54 years as an investor, I’ve seen my share of gold bull markets. But nothing comes close to the rall...Weiss Ratings | Sponsored379 passengers walked away from thisElon Musk just wrote a $51 million check to back this material’s next phase… Because it’s not just saving l...True Market Insiders | Sponsored12 “perfect” stocksJoin the Dream Team and see how we can guarantee stock market wins Credentials are a good thing, especiall...Zacks | SponsoredWhen This Happens, You Don’t Wait. You Act.This same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredHedge fund legend humiliates Bitcoin tradersLarry Benedict made $274 million trading on Wall Street… Barron’s ranked his hedge fund in the top 1% world...Brownstone Research | SponsoredIsrael-Iran WAR Could Destroy Trump's PresidencyThe missiles are already flying. Israel and Iran are now in direct military conflict — and this couldn't ha...American Alternative | SponsoredYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Abeona Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Abeona Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy ABEO Stock Free ABEO Stock Alerts